The Best and Worst New ETFs of 2024
More than 650 new ETFs have launched as of Dec. 5, 2024, beating last year’s record by more than 150. Each year has marked a ...
2 ex-CEOs of Washington biotech company face 20 years after fraud convictions
A federal jury this week in Maryland convicted two ex-CEOs of a Washington biotech company for their role in a multi-million ...
Analysts Conflicted on These Materials Names: SSR Mining (SSRM) and Cabot (CBT)
Analysts have been eager to weigh in on the Materials sector with new ratings on SSR Mining (SSRM – Research Report) and Cabot (CBT – Research ...
Elon Musk says DOGE's work will be public — legally, it has to be
Legal experts say Elon Musk's DOGE must comply with a decades-old transparency law.
Buy Palantir Stock Before It Soars 200% to $500 Billion, According to a Wall Street Analyst
What makes that call particularly surprising is that most pundits are still skeptical about Palantir. Among the 20 analysts ...
Bitcoin has surpassed the $100,000 mark as the post-election rally continues. What’s next?
Bitcoin topped $100,000 for the first time as a massive rally in the world’s most popular cryptocurrency, largely accelerated ...
SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts
The US dropped its investigation into General Industrial Partners LLP, the parent company of Gotham City Research, which ...
Poll: Most voters are confident in 2024 election results
The 2024 general election was run and administered well, a large majority of voters polled told the Pew Research Center.
Mizuho Securities Remains a Buy on ADMA Biologics (ADMA)
In a report released yesterday, Anthony Petrone from Mizuho Securities reiterated a Buy rating on ADMA Biologics (ADMA – Research Report). The ...